Business Description
Marker Therapeutics is a US-based clinical-stage company focused on developing cancer treatments that harness the body's own immune cells to fight tumors. Their approach uses naturally occurring T cells ? without genetic modification ? that are trained to recognize and destroy cancer cells. The company is currently running early-stage clinical trials for treatments targeting blood cancers and pancreatic cancer. Founded in 1999 and based in Houston, Texas, the company was previously known as TapImmune before rebranding in 2018.
